Rubén Gil‐Redondo
CIC bioGUNE(ES)
Publications by Year
Research Areas
Metabolomics and Mass Spectrometry Studies, Liver Disease Diagnosis and Treatment, Computational Drug Discovery Methods, Diet and metabolism studies, Inflammatory Bowel Disease
Most-Cited Works
- → SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum(2020)224 cited
- → MM-ISMSA: An Ultrafast and Accurate Scoring Function for Protein–Protein Docking(2012)74 cited
- → Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles(2022)54 cited
- → Uneven metabolic and lipidomic profiles in recovered COVID‐19 patients as investigated by plasma NMR metabolomics(2021)49 cited
- → Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts(2021)48 cited
- → Insights into Nucleotide Recognition by Cell Division Protein FtsZ from a mant-GTP Competition Assay and Molecular Dynamics(2010)46 cited
- → Abnormal concentration of porphyrins in serum from COVID‐19 patients(2020)40 cited
- → Randomised clinical trial: a leucine‐metformin‐sildenafil combination (NS‐0200) vs placebo in patients with non‐alcoholic fatty liver disease(2018)40 cited
- → A molecular signature for the metabolic syndrome by urine metabolomics(2021)39 cited
- → The fatty acids of sphingomyelins and ceramides in mammalian tissues and cultured cells: Biophysical and physiological implications(2018)38 cited